We develop bioprinted tissue therapeutics by combining our proprietary bioprinting technology, therapeutic cells, biomaterials, and computational tissue design.
These tissues are designed and manufactured to be biologically functional, immune-protective, and suitable for surgical implantation, and have the potential to transform how we treat currently incurable diseases like type 1 diabetes and liver disease.